Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?

Rheumatology (Oxford). 2011 Aug;50(8):1523-5. doi: 10.1093/rheumatology/ker144. Epub 2011 May 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Ear Cartilage / pathology
  • Etanercept
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunologic Factors / adverse effects*
  • Infliximab
  • Male
  • Middle Aged
  • Polychondritis, Relapsing / drug therapy
  • Polychondritis, Relapsing / etiology*
  • Polychondritis, Relapsing / pathology
  • Prednisone / therapeutic use
  • Receptors, Tumor Necrosis Factor
  • Spondylitis, Ankylosing / complications
  • Spondylitis, Ankylosing / drug therapy
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Glucocorticoids
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept
  • Prednisone